#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema Still's disease Mantle cell lymphoma stage III Hyperchylomicronaemia Lymphangiosarcoma Dementia Malignant central nervous system neoplasm Infection in an immunocompromised host Immune-mediated enterocolitis Squamous cell carcinoma of the cervix Glomerulonephritis chronic Short stature homeobox gene mutation Frostbite Chondrosarcoma metastatic Familial haemophagocytic lymphohistiocytosis More trials…

    Learn about Rare Diseases

    Turner’s syndrome – Diagnostics Progressive multifocal leukoencephalopathy – Diagnostics Prader-Willi syndrome – Trials in Disease Alagille syndrome – Diagnostics Rhabdomyosarcoma – Diagnostics Phenylketonuria – Basic Information Bronchiolitis obliterans syndrome – Diagnostics Uterine leiomyosarcoma – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Mastocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fexofenadine Taplucainium Chloride Tebentafusp Deferoxamine Mesilate Omp10 Envudeucitinib HUMAN PLASMA Xylitol Calcium Lactate Gluconate Cemiplimab Zinc Sulphate Heptahydrate L-ARGININE Efmoroctocog Alfa Carbamazepine Cyanocobalamin S230815-2 Safinamide Protein C Lumasiran Cemdisiran More therapies…

    Learn about Your Condition

    Gastrooesophageal cancer Device related infection Duchenne muscular dystrophy Alcoholic liver disease Asymptomatic HIV infection Neutropenia Acute cardiac event Encephalitis autoimmune Milk allergy Corneal graft failure Urethral valves Foot deformity Colon cancer stage IV Cerebral haemorrhage Lysosomal storage disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Metabolic Impairment in ALS and TIA Patients Using Hyperpolarized Pyruvate MRI

    Recruiting

    2 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Pyruvic Acid
    Denmark

  • Study on Ovarian Stimulation Using Follitropin Delta and Dydrogesterone for Women Donating Eggs

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dydrogesterone
    • Follitropin Delta
    Belgium

  • Treatment with Mesenchymal Stromal Cells for Adults with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS-TEN) Affecting More Than 10% of Body Surface

    Recruiting

    1 1 1
    Investigated Diseases:
    • Toxic epidermal necrolysis
    Investigated Drugs:
    • Allogeneic Adipose-Derived Mesenchymal Stromal Cells, Ex-Vivo Expanded
    France

  • Study on Brain Changes in Alzheimer’s Disease Using Flutemetamol (18F) and Fludeoxyglucose (18F) in ALFA Project Participants

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Flutemetamol (18F)
    • Fludeoxyglucose (18F)
    Spain

  • Study on the Effects of Acetylsalicylic Acid and Cytisine for High-Risk Patients in Preventing Lung Cancer and Reducing Inflammation

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cytisine
    • Acetylsalicylic Acid
    Italy

  • Study on Clopidogrel and Dalteparin Sodium for Preventing Blood Clots in Pancreatic Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Clopidogrel
    • Dalteparin Sodium
    Norway
Previous Page
1 … 187 188 189 190 191 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!